Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Immunogenicity and Safety in Infants and Toddlers
NCT01890759Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2013
- Primary completion
- Apr 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal infection, meningitis, sponsored by Sanofi. Started Jun 2013; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infectionmeningitis
Beyond the preview
Go deeper on NCT01890759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890759.